| |
| |
|
| Insider
Information: |
Soloway Thomas P |
| Relationship: |
Executive Vice Preside... |
| City: |
Point Richmond |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
31,234 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$69,652 |
|
|
| Total
Shares |
31,234 |
|
|
| Total
Value |
$69,652 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Paratek Pharmaceuticals Inc |
PRTK |
SVP, Operations and CFO |
2011-12-01 |
0 |
2011-12-01 |
31,234 |
Premium* |
|
|
Audentes Therapeutics, Inc. |
BOLD |
Executive Vice Preside... |
2020-01-15 |
0 |
2019-02-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BOLD |
Audentes Therapeutics, In... |
Executive Vice President, CFO |
• – – |
2020-01-15 |
4 |
D |
$60.00 |
$11,003,040 |
D/D |
(183,384) |
0 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Executive Vice President, CFO |
• – – |
2020-01-08 |
4 |
OE |
$2.76 |
$494,897 |
D/D |
150,888 |
183,384 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Executive Vice President, CFO |
• – – |
2019-12-12 |
4 |
D |
$59.37 |
$1,789,352 |
D/D |
(30,139) |
32,496 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Executive Vice President, CFO |
• – – |
2019-12-12 |
4 |
OE |
$2.76 |
$114,248 |
D/D |
41,321 |
53,954 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Executive Vice President, CFO |
• – – |
2019-12-05 |
4 |
D |
$59.21 |
$29,901 |
D/D |
(505) |
21,314 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Executive Vice President, CFO |
• – – |
2019-09-05 |
4 |
D |
$31.02 |
$15,665 |
D/D |
(505) |
21,819 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Executive Vice President, CFO |
• – – |
2019-06-05 |
4 |
D |
$37.31 |
$37,646 |
D/D |
(1,009) |
22,324 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Executive Vice President, CFO |
• – – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
23,333 |
23,333 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
SVP, Operations and CFO |
• – – |
2011-12-01 |
4 |
AS |
$8.23 |
$528,485 |
D/D |
(62,670) |
0 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
SVP, Operations and CFO |
• – – |
2011-12-01 |
4 |
OE |
$0.88 |
$100,585 |
D/D |
62,670 |
37,520 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
SVP, Operations and CFO |
• – – |
2009-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
28,995 |
20,833 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
SVP, Operations and CFO |
• – – |
2009-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,239 |
2,239 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
